Lysophosphatidylcholine Isoforms as Clinical Markers of Colorectal Cancer and Pol

溶血磷脂酰胆碱亚型作为结直肠癌和 Pol 的临床标志物

• 批准号: 7789447
• 负责人: WON KYOO CHO
• 金额: --
• 依托单位: RLR VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7789447
• 关键词: 3 year old; Adenomatous Polyps; Adherence; Affect; African American; Aging; Alcohol consumption; Biochemical; Biological Markers; Blood specimen; Cancer Etiology; Cancer Patient; Cancerous; Carcinoma; Caring; Cell physiology; Cessation of life; Clinic; Clinical Markers; Colon; Colonic Adenoma; Colonic Polyps; Colonoscopy; Colorectal; Colorectal Cancer; Data; Development; Diabetes Mellitus; Diagnosis; Diagnostic; Diagnostic Neoplasm Staging; Diet; Disease; Early Diagnosis; Elderly; Evaluation; Family history of; Fasting; Female; Gender; Goals; Healthcare; Incidence; Indiana; Inflammatory Bowel Diseases; Lesion; Link; Lipids; Lysophosphatidylcholines; Malignant - descriptor; Malignant Neoplasms; Medical; Medical center; Minority; Molecular; Operative Surgical Procedures; Patients; Pilot Projects; Plasma; Polyps; Population; Population Study; Premalignant; Preparation; Protein Isoforms; Race; Recording of previous events; Reporting; Reproducibility; Research; Risk Factors; Role; Sampling; Second Primary Cancers; Sensitivity and Specificity; Smoking; Staging; Survival Rate; Test Result; Testing; Time; United States; United States Department of Veterans Affairs; Universities; Veterans; Visit; Work; abstracting; adenoma; cancer diagnosis; cancer risk; case control; clinically significant; colorectal cancer screening; cost; demographics; follow-up; improved; male; minimally invasive; new therapeutic target; patient population; prognostic; public health relevance; tool